Sentence examples for delay the entry of from inspiring English sources

Should these links fail, they have the potential to delay the entry of a screened baby into therapy after testing positive for a preventable disease.

Through building patent landscapes in Brazil, China, and India and interviews with manufacturers and experts in the field, we found intense patenting activity for the HPV and pneumococcal vaccines that could potentially delay the entry of new manufacturers.

Deciding to fight rather than open their switches, some of the Baby Bells used litigation to delay the entry of new competitors, and in 2001 such "raiders" as Covad, Focal Communications, McLeod, Northpoint and Winstar went bankrupt in one of the first signs of telecom's troubles.

"It is unacceptable that a company pays off its competitors to stay out of its market and delay the entry of cheaper medicines," said the Commissioner.

The evidence shows that subsidies to failing companies not only waste resources in keeping obsolete and inefficient firms alive, but also delay the entry of new and more efficient organizational models.

They are also concerned about a practice known as "evergreening," in which companies expand patent protections around a specific medicine there might be 20 or more patents around a specific drug in order to delay the entry of competing generic drugs onto the market.

These plays reached most of the principal towns of Turkistan, though in Bukhara and Khiva conservative Muslims delayed the entry of reformist theatre.

In 2005 regulators fined AstraZeneca 60 million euros for giving misleading information to several patent offices to extend the life of a blockbuster antacid drug, Losec, and delaying the entry of generic drugs.

This focus on deepening the European Union may have delayed the entry of new member nations from Eastern Europe, it is true, but that cannot be pinned on German reunification.

Earlier this year, Trump's military leadership had signaled that they needed more time to fully assess the implementation of the last significant piece of the Obama administration's approach, delaying the entry of transgender military recruits until the end of 2017.

Drugmakers often argue that because of increasing demands for data by regulators, the size and duration of clinical trials has risen steeply, delaying the entry of drugs to the market and bumping up their R&D spending.